查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266327

連續血糖監測系統市場：按組件、人口統計和最終用戶分類：2021-2031 年全球機會分析和行業預測

Continuous Glucose Monitoring Systems Market By Component, By Demography, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 284 Pages | 商品交期: 2-3個工作天內

價格

連續血糖監測系統市場價值在 2021 年為 66.266 億美元，到 2031 年將達到 317.082 億美元，從 2022 年到 2031 年預計將以 17.0% 的複合年增長率增長。

連續血糖監測系統 (CGM) 市場已成為一種很有前途的糖尿病管理工具，用於監測所有類型的糖尿病患者。 CGM 主要用於低血糖和高血糖患者。 市場上有幾種不同類型的 CGM 系統，包括間質液 CGM、血糖 CGM 和混合閉環 CGM，每種都具有獨特的功能和優勢。 這些系統具有多種優勢，包括改善血糖控制、減少指尖刺血測試的需要、更好地識別血糖模式以及提高生活質量。

連續血糖監測系統市場的增長受到以下因素的推動：糖尿病患者人數的增加、技術進步（例如能夠實時測量血糖的小型化和可穿戴設備的市場開放）以及患者對益處的認識不斷提高CGM.. 糖尿病患病率的增加正在推動人們廣泛採用 CGM 來監測血糖水平。 CGM 使用植入皮膚的傳感器測量間質液中的葡萄糖水平，並使用接收器顯示讀數。 例如，根據國際糖尿病聯合會 (IDF) 的數據，到 2021 年全球將有大約 5.37 億成年人患有糖尿病。 根據同一數據，超過四分之三的成人糖尿病患者生活在印度和中國等低收入和中等收入國家。 因此，糖尿病患病率的上升導致對 CGM 的需求增加，這反過來又促進了市場增長。

此外，越來越多的政府舉措和報銷政策是推動市場增長的主要因素。 例如，澳大利亞政府實施了一項持續血糖監測 (CGM) 計劃，作為國家糖尿病服務計劃 (NDSS) 的一部分，該計劃為符合條件的 1 型糖尿病患者提供獲得全額補貼的 Dexcom CGM 的機會。 該倡議旨在改善 1 型糖尿病患者的生活質量並降低糖尿病相關並發症的風險。 通過提供完全補貼的 CGM，政府正在幫助 1 型糖尿病患者更廣泛地使用和使用這些設備。 此外，增加 CGM 臨床評估的資金活動也有助於市場增長。 例如，歐盟委員會的Horizo□□n 2020計劃已提供285萬美元繼續開發無創觸摸血糖監測技術GlucoBeam。 因此，政府的此類舉措有助於公司繼續研究和測試新的 CGM，從而促進市場的增長。

然而，CGM 系統的高成本和設備複雜性限制了 CGM 的採用，從而限制了市場的增長。

另一方面，美國、加拿大等發達國家和世界其他地區對醫療器械的需求正在增加，而新興市場有望提供增長機會，為 CGM 帶來巨大的業務在預測期間。機會很可能會出現。

連續血糖監測系統市場根據組件、人口統計、最終用戶和地區進行細分。 基於組件，市場分為傳感器和發射器和接收器。 根據人口統計數據，市場分為兒科人群（□14 歲）和成人人群（>14 歲）。 按最終用戶劃分，市場分為醫院和診所、家庭保健等。 其他包括門診設置和診斷中心。

內容

第 1 章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資機會
  • 波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭激烈程度
  • 市場動態
    • 促進因素
      • 患糖尿病的人數增加
      • CGM 相對於傳統血糖監測設備的優勢
      • CGM 在家庭保健和 ICU 中的採用率很高
    • 抑制因素
      • 與 CGM 相關的副作用
      • CGM 的成本很高
    • 機會
      • 未確診患者人數眾多
      • CGM技術進展
  • 分析 COVID-19 對市場的影響

第 4 章連續血糖監測系統市場：按組件分類

  • 概覽
    • 市場規模和預測
  • 傳感器
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 發送器和接收器
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章連續血糖監測系統市場：按人口統計

  • 概覽
    • 市場規模和預測
  • 兒童人口
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 成年人口
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章連續血糖監測系統市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院和診所
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 家庭保健
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章連續血糖監測系統市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 各組成部分的市場規模和預測
    • 市場規模和預測：按人口統計
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
  • 歐洲
    • 主要趨勢和機會
    • 各組成部分的市場規模和預測
    • 市場規模和預測：按人口統計
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 俄羅斯
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 荷蘭
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 挪威
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 瑞典
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 丹麥
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 芬蘭
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
  • 亞太地區
    • 主要趨勢和機會
    • 各組成部分的市場規模和預測
    • 市場規模和預測：按人口統計
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 新西蘭
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 菲律賓
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 各組成部分的市場規模和預測
    • 市場規模和預測：按人口統計
    • 最終用戶的市場規模和預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 委內瑞拉
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 阿根廷
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測
      • 其他拉美地區
      • 主要市場趨勢、增長動力和機遇
      • 各組成部分的市場規模和預測
      • 市場規模和預測：按人口統計
      • 最終用戶的市場規模和預測

第 8 章競爭格局

  • 介紹
  • 關鍵成功策略
  • 排名前 10 位的玩家產品映射
  • 競爭儀表板
  • 競爭熱圖
  • 2021 年最佳球員排名

第 9 章公司簡介

  • Medtronic plc
  • Abbott Laboratories
  • DexCom, Inc.
  • Senseonics
  • Johnson & Johnson
  • A. Menarini Diagnostics S.r.l
  • Novo Nordisk A/S
  • GlySens Incorporated
  • Ypsomed AG
  • F. Hoffman-La Roche Ltd
Product Code: A01466

The continuous glucose monitoring systems market was valued at $6,626.6 million in 2021, and is estimated to reach $31,708.2 million by 2031, growing at a CAGR of 17.0% from 2022 to 2031.The continuous glucose monitoring systems (CGMs) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. CGMs are mainly used by patients suffering from hypo and hyperglycemic conditions. There are several different types of CGM systems available in the market, each with its own set of features and benefits such as interstitial fluid CGMs, blood glucose CGMs, and hybrid closed loop CGMs. These systems offer various advantages such as improved glucose control, reduced need for fingerstick testing, increased awareness of glucose patterns, and improved quality of life.

The continuous glucose monitoring systems market growth is driven by increase in number of patients suffering from diabetes; rise in technological advancements such as the development of miniaturized and wearable devices that can provide real-time glucose readings; and increase in patient awareness about be benefits of CGMs. The rise in prevalence of diabetes propels high adoption of CGMs for monitoring glucose levels. The sensor is implanted in the layer of skin which measure glucose levels in the interstitial fluid and a receiver displays the readings. For instance, according to International Diabetes Federation (IDF), about 537 million adults are living with diabetes in 2021, across the globe. In addition, as per the same source, over 3 in 4 adults with diabetes live in low and middle-income countries such as India and China. Thus, rise in the prevalence of diabetes has resulted in increased demand for CGMs, which, in turn, contribute to the market growth.

Furthermore, increase in government initiatives and reimbursement policies are the key factors that boost the market growth. For instance, the Australian Government has implemented the continuous glucose monitoring (CGM) Initiative as part of the National Diabetes Services Scheme (NDSS) to provide access to fully subsidized Dexcom CGMs for eligible people with Type 1 diabetes. This initiative is designed to improve the quality of life for people with Type 1 diabetes and reduce the risk of complications associated with the condition. By providing access to fully subsidized CGMs, the government is helping to make these devices more widely available and accessible to people with Type 1 diabetes. Furthermore, rise in funding activities to conduct the clinical evaluations of CGMs, further contribute towards the market growth. For instance, European Commission's Horizon 2020 program provided funding of $2.85 million for the continued development of non-invasive touch glucose monitoring technology, GlucoBeam. Therefore, such initiatives taken by government supports the company to continue the research and testing of novel CGMs, which, in turn, boost the market growth.

However, the high cost of CGM systems, and complexity of devices limit the adoption of CGMs, which, in turn, restrains the market growth.

On the other hand, increased demand of medical devices in the developed countries such as the U.S., Canada, and rest of world and growth potential in emerging markets expected to create immense opportunities for CGMs during the forecast period.

The continuous glucose monitoring systems market is segmented on the basis of component, demography, end user, and region. On the basis of component, the market is classified into sensors and transmitters & receivers. On the basis of demography, the market is segmented into child population (≤14 years) and adult population (>14 years). On the basis of end user, the market is classified into hospitals & clinics, home healthcare, and others. The others include ambulatory settings and diagnostic center.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, Netherlands, Norway, Sweden, Denmark, Finland, and rest of Europe), Asia-Pacific (India, China, Australia, Japan, South Korea, New Zealand, Philippines, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Venezuela, Argentina, and rest of LAMEA).

Major key players that operate in the global continuous glucose monitoring systems market are: A. Menarini, Diagnostics S.r.l, Abbott Laboratories, DexCom, Inc., F. Hoffman-La Roche Ltd, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Senseonics, and Ypsomed AG.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the continuous glucose monitoring systems market analysis from 2021 to 2031 to identify the prevailing continuous glucose monitoring systems market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the continuous glucose monitoring systems market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global continuous glucose monitoring systems market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Demography

  • Child Population
  • Adult Population

By End User

  • Home healthcare
  • Others
  • Hospital and Clinics

By Component

  • Transmitters and Receivers 
  • Sensors 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Norway
    • Sweden
    • Denmark
    • Finland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Philippines
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Venezuela 
    • Argentina 
    • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • DexCom, Inc.
  • Johnson & Johnson
  • F. Hoffman-La Roche Ltd
  • GlySens Incorporated
  • Novo Nordisk A/S
  • Abbott Laboratories
  • Senseonics
  • A. Menarini Diagnostics S.r.l
  • Ypsomed AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in number of people suffering from diabetes
      • 3.4.1.2. Benefits of CGMs over conventional glucose monitoring devices
      • 3.4.1.3. High adoption rate of CGMs in home healthcare and ICUs
    • 3.4.2. Restraints
      • 3.4.2.1. Adverse effects associated with CGMs
      • 3.4.2.2. High cost of CGMs
    • 3.4.3. Opportunities
      • 3.4.3.1. High undiagnosed patient population
      • 3.4.3.2. Technological advancement in CGMs
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Sensors 
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Transmitters and Receivers 
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Child Population
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Adult Population
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital and Clinics
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Home healthcare
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Component
    • 7.2.3. Market size and forecast, by Demography
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Component
      • 7.2.5.1.3. Market size and forecast, by Demography
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Component
      • 7.2.5.2.3. Market size and forecast, by Demography
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Component
      • 7.2.5.3.3. Market size and forecast, by Demography
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Component
    • 7.3.3. Market size and forecast, by Demography
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Component
      • 7.3.5.1.3. Market size and forecast, by Demography
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Component
      • 7.3.5.2.3. Market size and forecast, by Demography
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Component
      • 7.3.5.3.3. Market size and forecast, by Demography
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Component
      • 7.3.5.4.3. Market size and forecast, by Demography
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Russia
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Component
      • 7.3.5.5.3. Market size and forecast, by Demography
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Spain
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Component
      • 7.3.5.6.3. Market size and forecast, by Demography
      • 7.3.5.6.4. Market size and forecast, by End User
      • 7.3.5.7. Netherlands
      • 7.3.5.7.1. Key market trends, growth factors and opportunities
      • 7.3.5.7.2. Market size and forecast, by Component
      • 7.3.5.7.3. Market size and forecast, by Demography
      • 7.3.5.7.4. Market size and forecast, by End User
      • 7.3.5.8. Norway
      • 7.3.5.8.1. Key market trends, growth factors and opportunities
      • 7.3.5.8.2. Market size and forecast, by Component
      • 7.3.5.8.3. Market size and forecast, by Demography
      • 7.3.5.8.4. Market size and forecast, by End User
      • 7.3.5.9. Sweden
      • 7.3.5.9.1. Key market trends, growth factors and opportunities
      • 7.3.5.9.2. Market size and forecast, by Component
      • 7.3.5.9.3. Market size and forecast, by Demography
      • 7.3.5.9.4. Market size and forecast, by End User
      • 7.3.5.10. Denmark
      • 7.3.5.10.1. Key market trends, growth factors and opportunities
      • 7.3.5.10.2. Market size and forecast, by Component
      • 7.3.5.10.3. Market size and forecast, by Demography
      • 7.3.5.10.4. Market size and forecast, by End User
      • 7.3.5.11. Finland
      • 7.3.5.11.1. Key market trends, growth factors and opportunities
      • 7.3.5.11.2. Market size and forecast, by Component
      • 7.3.5.11.3. Market size and forecast, by Demography
      • 7.3.5.11.4. Market size and forecast, by End User
      • 7.3.5.12. Rest of Europe
      • 7.3.5.12.1. Key market trends, growth factors and opportunities
      • 7.3.5.12.2. Market size and forecast, by Component
      • 7.3.5.12.3. Market size and forecast, by Demography
      • 7.3.5.12.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Component
    • 7.4.3. Market size and forecast, by Demography
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Component
      • 7.4.5.1.3. Market size and forecast, by Demography
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Component
      • 7.4.5.2.3. Market size and forecast, by Demography
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Component
      • 7.4.5.3.3. Market size and forecast, by Demography
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Component
      • 7.4.5.4.3. Market size and forecast, by Demography
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Component
      • 7.4.5.5.3. Market size and forecast, by Demography
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. New Zealand
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Component
      • 7.4.5.6.3. Market size and forecast, by Demography
      • 7.4.5.6.4. Market size and forecast, by End User
      • 7.4.5.7. Philippines
      • 7.4.5.7.1. Key market trends, growth factors and opportunities
      • 7.4.5.7.2. Market size and forecast, by Component
      • 7.4.5.7.3. Market size and forecast, by Demography
      • 7.4.5.7.4. Market size and forecast, by End User
      • 7.4.5.8. Rest of Asia-Pacific
      • 7.4.5.8.1. Key market trends, growth factors and opportunities
      • 7.4.5.8.2. Market size and forecast, by Component
      • 7.4.5.8.3. Market size and forecast, by Demography
      • 7.4.5.8.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Component
    • 7.5.3. Market size and forecast, by Demography
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Component
      • 7.5.5.1.3. Market size and forecast, by Demography
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Component
      • 7.5.5.2.3. Market size and forecast, by Demography
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Component
      • 7.5.5.3.3. Market size and forecast, by Demography
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Venezuela 
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Component
      • 7.5.5.4.3. Market size and forecast, by Demography
      • 7.5.5.4.4. Market size and forecast, by End User
      • 7.5.5.5. Argentina 
      • 7.5.5.5.1. Key market trends, growth factors and opportunities
      • 7.5.5.5.2. Market size and forecast, by Component
      • 7.5.5.5.3. Market size and forecast, by Demography
      • 7.5.5.5.4. Market size and forecast, by End User
      • 7.5.5.6. Rest of LAMEA
      • 7.5.5.6.1. Key market trends, growth factors and opportunities
      • 7.5.5.6.2. Market size and forecast, by Component
      • 7.5.5.6.3. Market size and forecast, by Demography
      • 7.5.5.6.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. DexCom, Inc.
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Senseonics
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Key strategic moves and developments
  • 9.5. Johnson & Johnson
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. A. Menarini Diagnostics S.r.l
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Novo Nordisk A/S
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. GlySens Incorporated
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Ypsomed AG
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. F. Hoffman-La Roche Ltd
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 02. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 05. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 08. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 13. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 14. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 15. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 17. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 18. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 19. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 20. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 21. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 24. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 26. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 34. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 36. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 37. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 39. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 40. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 42. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 43. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 45. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 46. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 48. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 49. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 51. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 52. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 54. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 55. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 57. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 58. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 60. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 61. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 73. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 74. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 77. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 83. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 84. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 85. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 86. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 88. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 89. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 94. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 97. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 98. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 99. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 100. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 101. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 102. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 103. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 104. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 105. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 107. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 108. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 109. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 110. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 111. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 115. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 116. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 117. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 118. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 119. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 120. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 121. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 122. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 123. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 124. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 125. DEXCOM, INC.: KEY EXECUTIVES
  • TABLE 126. DEXCOM, INC.: COMPANY SNAPSHOT
  • TABLE 127. DEXCOM, INC.: PRODUCT SEGMENTS
  • TABLE 128. DEXCOM, INC.: PRODUCT PORTFOLIO
  • TABLE 129. DEXCOM, INC.: KEY STRATERGIES
  • TABLE 130. SENSEONICS: KEY EXECUTIVES
  • TABLE 131. SENSEONICS: COMPANY SNAPSHOT
  • TABLE 132. SENSEONICS: PRODUCT SEGMENTS
  • TABLE 133. SENSEONICS: PRODUCT PORTFOLIO
  • TABLE 134. SENSEONICS: KEY STRATERGIES
  • TABLE 135. JOHNSON & JOHNSON: KEY EXECUTIVES
  • TABLE 136. JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 137. JOHNSON & JOHNSON: PRODUCT SEGMENTS
  • TABLE 138. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 139. A. MENARINI DIAGNOSTICS S.R.L: KEY EXECUTIVES
  • TABLE 140. A. MENARINI DIAGNOSTICS S.R.L: COMPANY SNAPSHOT
  • TABLE 141. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT SEGMENTS
  • TABLE 142. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT PORTFOLIO
  • TABLE 143. NOVO NORDISK A/S: KEY EXECUTIVES
  • TABLE 144. NOVO NORDISK A/S: COMPANY SNAPSHOT
  • TABLE 145. NOVO NORDISK A/S: PRODUCT SEGMENTS
  • TABLE 146. NOVO NORDISK A/S: PRODUCT PORTFOLIO
  • TABLE 147. GLYSENS INCORPORATED: KEY EXECUTIVES
  • TABLE 148. GLYSENS INCORPORATED: COMPANY SNAPSHOT
  • TABLE 149. GLYSENS INCORPORATED: PRODUCT SEGMENTS
  • TABLE 150. GLYSENS INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 151. YPSOMED AG: KEY EXECUTIVES
  • TABLE 152. YPSOMED AG: COMPANY SNAPSHOT
  • TABLE 153. YPSOMED AG: PRODUCT SEGMENTS
  • TABLE 154. YPSOMED AG: PRODUCT PORTFOLIO
  • TABLE 155. F. HOFFMAN-LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 156. F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 157. F. HOFFMAN-LA ROCHE LTD: PRODUCT SEGMENTS
  • TABLE 158. F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY COUNTRY 2021-2031(%)
  • FIGURE 13. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY COUNTRY 2021-2031(%)
  • FIGURE 16. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY REGION, 2021
  • FIGURE 21. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 22. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. VENEZUELA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. ARGENTINA  CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2021
  • FIGURE 57. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. DEXCOM, INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. DEXCOM, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 65. JOHNSON & JOHNSON: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 66. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 67. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 68. NOVO NORDISK A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 69. NOVO NORDISK A/S: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. NOVO NORDISK A/S: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 71. YPSOMED AG: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 72. YPSOMED AG: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 73. YPSOMED AG: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 74. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 75. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 76. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)